文献
J-GLOBAL ID:201702221120241463
整理番号:17A1210262
ALK陽性肺非小細胞癌(J ALEX)患者におけるアレクチニブとクリゾチニブ:非盲検,無作為化第3相試験【Powered by NICT】
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
著者 (23件):
Hida Toyoaki
(Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan)
,
Nokihara Hiroshi
(Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Kondo Masashi
(Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Kim Young Hak
(Department of Respiratory Medicine, Kyoto University, Kyoto, Japan)
,
Azuma Koichi
(Institution Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan)
,
Seto Takashi
(Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan)
,
Takiguchi Yuichi
(Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan)
,
Nishio Makoto
(Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Yoshioka Hiroshige
(Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan)
,
Imamura Fumio
(Department of Thoracic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan)
,
Hotta Katsuyuki
(Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan)
,
Watanabe Satoshi
(Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
,
Goto Koichi
(Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan)
,
Satouchi Miyako
(Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan)
,
Kozuki Toshiyuki
(Department of Thoracic Oncology and Medicine, Shikoku Cancer Center, Matsuyama, Japan)
,
Shukuya Takehito
(Department of Respiratory Medicine, Juntendo University, Tokyo, Japan)
,
Nakagawa Kazuhiko
(Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan)
,
Mitsudomi Tetsuya
(Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan)
,
Yamamoto Nobuyuki
(Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan)
,
Asakawa Takashi
(Clinical Science and Strategy Department, Chugai Pharmaceutical, Tokyo, Japan)
,
Asabe Ryoichi
(Clinical Study Management Department, Chugai Pharmaceutical, Tokyo, Japan)
,
Tanaka Tomohiro
(Clinical Science and Strategy Department, Chugai Pharmaceutical, Tokyo, Japan)
,
Tamura Tomohide
(Thoracic Center, St. Luke’s International Hospital, Tokyo, Japan)
資料名:
Lancet
(Lancet)
巻:
390
号:
10089
ページ:
29-39
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)